Related references
Note: Only part of the references are listed.Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery
Seunguk Oh et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy
Daniel A. Vallera et al.
LEUKEMIA RESEARCH (2009)
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model
D. A. Vallera et al.
GUT (2008)
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
John H. Sampson et al.
NEURO-ONCOLOGY (2008)
An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
Masanori Onda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model
Brad J. Stish et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
A bispecific recombinant cytotoxin (DTEGF13) targeting human interleukin-13 and epidermal growth factor receptors in a mouse xenograft model of prostate cancer
Brad J. Stish et al.
CLINICAL CANCER RESEARCH (2007)
Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheter
Seunguk Oh et al.
JOURNAL OF NEUROSURGERY (2007)
Lessons learned in the development of targeted therapy for malignant gliomas
Antonio M. P. Omuro et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Increasing anticarcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv
Brad J. Stish et al.
CLINICAL CANCER RESEARCH (2007)
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the Cintredekin Besudotox Intraparenchymal Study Group
Sandeep Kunwar et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice
Edward Rustamzadeh et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient
E Rustamzadeh et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy
Mitomu Kioi et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2006)
Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the Sleeping Beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma
JR Ohlfest et al.
MOLECULAR THERAPY (2005)
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-Cell malignancies
RJ Kreitman et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice
DA Vallera et al.
LEUKEMIA RESEARCH (2005)
A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model
DA Todhunter et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme
GO Hjortland et al.
JOURNAL OF NEUROSURGERY (2004)
Interstitial infusion of IL13-PE38QQR in the rat brain stem
MM Souweidane et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside
SR Husain et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Diphtheria toxin-epidermal growth factor fusion protein and pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells
TF Liu et al.
BIOCONJUGATE CHEMISTRY (2003)
Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals
O Engebraaten et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain
TC Elleman et al.
BIOCHEMISTRY (2001)
Limitations of the C6/Wistar rat intracerebral glioma model: Implications for evaluating immunotherapy
AT Parsa et al.
NEUROSURGERY (2000)
Expression of a restrictive receptor for interleukin 13 is associated with glial transformation
W Debinski et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Share Paper
